Knapp RC - Search Results

1

The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma.

Goodman HM, Harlow BL, Sheets EE, Muto MG, Brooks S, Steller M, Knapp RC, Berkowitz RS. Goodman HM, et al. Among authors: knapp rc. Gynecol Oncol. 1992 Sep;46(3):367-71. doi: 10.1016/0090-8258(92)90234-a. Gynecol Oncol. 1992. PMID: 1526516

2

Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence.

Goodman HM, Buttlar CA, Niloff JM, Welch WR, Marck A, Feuer EJ, Lahman EA, Jenison EL, Knapp RC. Goodman HM, et al. Among authors: knapp rc. Gynecol Oncol. 1989 May;33(2):241-7. doi: 10.1016/0090-8258(89)90560-x. Gynecol Oncol. 1989. PMID: 2649424 Review.

3

Adenocarcinoma of the cervical stump.

Goodman HM, Niloff JM, Buttlar CA, Welch WR, Marck A, Feuer EJ, Lahman EA, Jenison E, Knapp RC. Goodman HM, et al. Among authors: knapp rc. Gynecol Oncol. 1989 Nov;35(2):188-92. doi: 10.1016/0090-8258(89)90041-3. Gynecol Oncol. 1989. PMID: 2807009

4

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC, Berkowitz RS. Mok SC, et al. Among authors: knapp rc. Gynecol Oncol. 1994 Feb;52(2):247-52. doi: 10.1006/gyno.1994.1040. Gynecol Oncol. 1994. PMID: 8314147

5

Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.

Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, Goodman HM, Sheets EE, Berkowitz RS, Lau CC. Tsao SW, et al. Among authors: knapp rc. Gynecol Oncol. 1993 Jan;48(1):5-10. doi: 10.1006/gyno.1993.1002. Gynecol Oncol. 1993. PMID: 8423021

6

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125.

Muto MG, Finkler NJ, Kassis AI, Lepisto EM, Knapp RC. Muto MG, et al. Among authors: knapp rc. Gynecol Oncol. 1990 Aug;38(2):244-8. doi: 10.1016/0090-8258(90)90049-q. Gynecol Oncol. 1990. PMID: 2387541

7

Preoperative serum CA-125 levels in borderline tumors of the ovary.

Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, Bell DA. Rice LW, et al. Among authors: knapp rc. Gynecol Oncol. 1992 Aug;46(2):226-9. doi: 10.1016/0090-8258(92)90260-p. Gynecol Oncol. 1992. PMID: 1500026

8

Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433).

Brooks SE, Timmerman J, Lau CC, Tsao SW, Knapp RC, Sheets EE. Brooks SE, et al. Among authors: knapp rc. Gynecol Oncol. 1991 Sep;42(3):265-72. doi: 10.1016/0090-8258(91)90356-a. Gynecol Oncol. 1991. PMID: 1720110

9

Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer.

Finkler NJ, Muto MG, Kassis AI, Weadock K, Tumeh SS, Zurawski VR Jr, Knapp RC. Finkler NJ, et al. Among authors: knapp rc. Gynecol Oncol. 1989 Sep;34(3):339-44. doi: 10.1016/0090-8258(89)90169-8. Gynecol Oncol. 1989. PMID: 2767526

10

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Muto MG, et al. Among authors: knapp rc. Cancer Res. 1995 Feb 1;55(3):490-2. Cancer Res. 1995. PMID: 7834614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters